Mouse Cholinergic Receptor, Muscarinic 2 (CHRM2) Protein

Product specifications

Proteins and Peptides

Cholinergic Receptor, Muscarinic 2 (CHRM2)

E. coli

Mouse

Unconjugated

Concentration: Prior to lyophilization: 200 µg/ml
Sequence Fragment: Please enquire.
Tag: N-terminal His tag

Recombinant

> 90%

1 mg

5 mg

Lyophilized To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.

WB, SDS-PAGE

Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.

Shipped within 1-2 months.

Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.

No

CHRM2 ,M2 muscarinic acetylcholine receptor,AChR M2,Chrm-2,cholinergic receptor muscarinic 2,cholinergic receptor,cholinergic receptor, muscarinic 2, cardiac,M2 receptor,HM2

Protein CHRM2

RUO

This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

CHRM2 encodes the cholinergic receptor muscarinic 2, which is another member of the G protein-coupled receptor family and primarily couples to Gi/o proteins. Activation of CHRM2 leads to inhibition of adenylate cyclase, thereby reducing intracellular cyclic AMP (cAMP) levels and leading to decreased cellular excitability. CHRM2 is expressed in the heart, brainstem, and vagus nerve, where it plays a key role in modulating cardiovascular function and parasympathetic nervous system activity. In the heart, CHRM2 activation slows heart rate by reducing the firing rate of sinoatrial (SA) node cells, a mechanism vital for maintaining resting heart rate and promoting vagal tone. In the brain, CHRM2 is implicated in processes related to cognition, mood regulation, and stress response, making it relevant for disorders such as depression and anxiety. Genetic variations in CHRM2 have been associated with cognitive performance and psychiatric conditions, including alcohol dependence. Pharmacologically, CHRM2 antagonists are used in cardiac treatment to counteract excessive parasympathetic activity, while selective agonists may have potential therapeutic applications in improving memory function and treating mood disorders.

Related Products

Human CHRM2 (Cholinergic Receptor, Muscarinic 2) ELISA Kit

Ver Producto

Mouse CHRM2 (Cholinergic Receptor, Muscarinic 2) ELISA Kit

Ver Producto

Rat CHRM2 (Cholinergic Receptor, Muscarinic 2) ELISA Kit

Ver Producto